Livelyhood

Livelyhood

The Gut Punch Weekly #14

Americans are snacking less, Novo bets $1B on new drug, Rybelsus' cardiovascular impacts are mixed, Danone adapts marketing strategy for the GLP-1 era, and more!

Apr 02, 2025
∙ Paid
User's avatar

Continue reading this post for free, courtesy of Lance Lively.

Or purchase a paid subscription.
© 2026 Lance Lively · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture